Credit: Canva
Low-dose CT chest scans could help detect pneumonia in at-risk patients while exposing them to only small amounts of radiation, a new study has found. The research, published in Radiology: Cardiothoracic Imaging, shows that ultra-low-dose scans can effectively detect pneumonia in patients with compromised immune systems, enabling doctors to treat the infection before it becomes life-threatening. According to the researchers, these scans expose patients to just 2% of the radiation dose used in a standard CT scan.
"This study paves the way for safer, AI-driven imaging that reduces radiation exposure while preserving diagnostic accuracy,” lead researcher Dr Maximiliano Klug, a radiologist with the Sheba Medical Center in Ramat Gan, Israel, said in a news release. He added that CT scans are the gold standard for detecting pneumonia but there are concerns regarding the risk posed by repeated exposure to radiation. There is a solution- ultra-low-dose CT scan. However, the problem is that these scans can be grainy and hard to read, researchers said.
Study Gives Solution To This
To overcome that, Klug's team developed an AI program that could help "de-noise" low-dose scans, making them sharper and easier to read. Between September 2020 and December 2022, 54 patients with compromised immune systems who had fevers underwent a pair of chest CT scans -- a normal dose scan and an ultra-low-dose scan. The AI program cleaned up the low-dose scan, and then both sets of images were given to a pair of radiologists for assessment. Radiologists had 100% accuracy in detecting pneumonia and other lung problems with the AI-cleaned low-dose scans, but 91% to 98% accuracy in examining the scans that hadn’t been improved through AI, results show.
"This pilot study identified infection with a fraction of the radiation dose," Klug said. "This approach could drive larger studies and ultimately reshape clinical guidelines, making denoised ultra-low dose CT the new standard for young immunocompromised patients.
How Can You Detect Pneumonia?
Pneumonia is a lung infection that causes the air sacs in the lungs to fill with fluid or pus and can be caused by bacteria, viruses, or fungi. The symptoms can range from milk to severe, which includes:
Coughing with or without cough
Fever
Chills
Trouble breathing
Chest pain, especially when breathing deeply or coughing
Sweating or chills
Rapid heart rate
Loss of appetite
Bluish skin, lips, and nails
Confusion.
How to detect Pneumonia in coughing newborns and toddlers?
Pneumonia can severely affect newborns and young children as their lungs are comparatively more sensitive. As per Dr Goyal, young children can cough for various reasons including seasonal infections and tonsillitis, which is very common in this age group. But if they look visibly irritable and have poor sleep patterns, then parents must reach out to an expert. "I am not saying that parents must visit a hospital but any local paediatrician would be able to detect pneumonia in your kid.
Credits: Canva
In what researchers are calling an important scientific advance, a team in the US has shown through animal experiments that Alzheimer’s disease may be reversible, overturning a belief that has shaped medical thinking for more than 100 years. For generations, the neurodegenerative condition was considered permanent and progressive. The findings, published in Cell Reports Medicine, are based on multiple preclinical mouse models as well as examinations of human Alzheimer’s brain tissue.
The study found that preserving a healthy balance of NAD, a molecule central to cellular energy production, could both prevent and reverse Alzheimer’s-related damage. NAD plays a key role in brain function and is now seen as a major contributor to the disease process. Researchers also observed that NAD levels drop much more sharply in the brains of people with Alzheimer’s, a pattern that was mirrored in mouse models of the condition.
Don't Miss: Taking Tramadol? Scientists Warn It May Cause More Harm Than Relief
“We were extremely encouraged by what we observed,” said Andrew A. Pieper, the study’s senior author and Director of the Brain Health Medicines Center at the Harrington Discovery Institute, University Hospitals, as per Sciencedirect. “By restoring the brain’s energy balance, we saw both structural and functional recovery in mice with advanced Alzheimer’s.”
Pieper noted that the effect appeared consistently across two very different mouse models, each driven by separate genetic mechanisms linked to Alzheimer’s in humans. “Seeing recovery in models caused by distinct genetic pathways strengthens the case that restoring NAD balance in the brain could have real therapeutic potential for patients,” he said.
For the study, researchers examined mice engineered to carry genetic mutations known to cause Alzheimer’s disease in people. One group of mice carried multiple human mutations affecting amyloid processing, while the second group carried a human mutation in the tau protein.
After confirming that brain NAD levels dropped sharply in both human Alzheimer’s tissue and mouse models, the team tested whether stopping this decline before symptoms appeared could prevent disease, and whether restoring NAD levels after the disease had progressed could reverse it. To do this, they used a well-studied drug called P7C3-A20 to restore NAD balance in the brain.
The results were striking. Not only did maintaining NAD levels prevent Alzheimer’s from developing in mice, but starting treatment later, after the disease was already advanced, allowed the brain to repair the main pathological damage caused by the genetic mutations. In both mouse models, cognitive abilities were fully restored.
In Alzheimer’s disease, NAD, short for nicotinamide adenine dinucleotide, is an essential coenzyme whose levels naturally decline with age. This decline disrupts energy production, mitochondrial health, DNA repair, and the ability of neurons to withstand stress. Research suggests that increasing NAD levels, often through precursors such as nicotinamide riboside, may reverse Alzheimer’s-related damage, improve memory, and correct abnormal RNA processing in animal models. Because of this, NAD has become a major area of focus for developing new Alzheimer’s therapies, according to the National Institutes of Health.
The findings also pave the way for further research and eventual testing in people. The technology behind the treatment is currently being developed for commercial use by Glengary Brain Health, a Cleveland-based company co-founded by Dr. Pieper.
“This recovery-based treatment approach now needs to be tested in carefully designed clinical trials to see if the benefits seen in animals can be replicated in humans,” Pieper said.
He added that future laboratory work will focus on identifying which components of brain energy balance matter most for recovery, exploring additional strategies that could complement this approach, and determining whether similar methods could work for other long-term, age-related neurodegenerative diseases as well.
Credits: Canva
Adenovirus, or what some people are calling the mystery disease is going to be the next worry in the UK, after superflu had already grappled the healthcare system. Along with H3N2 and its variant superclade K, people are now worrying about this mystery disease.
Adenovirus is highly contagious and causes mild cold or flu-like symptoms, though severe cases could lead to stomach flu and vomiting. Many describe this virus as 'heartier' than others. The reason is that the virus can survive longer on surfaces and even resist the common disinfectants used. This is what makes it highly transmissible.
As of now, there is no treatment for adenovirus, it could however be managed and monitored. What helps is regular handwashing and thorough cleaning of surfaces.
The good news is that cases of adenovirus are actually dropping in the UK, as confirmed lab reports. The cases last week were 1.2 per cent, whereas the week prior, it was at 1.7 per cent, as also reported by the Independent.
While a lot of the symptoms mimics of those in flu or COVID, including shortness of breath, a sore throat and or a runny nose. However, there are certain unique symptoms of adenovirus that include:
Other rare symptoms could also include impact on your bladder or nervous system. As viruses in your bladder can also cause urinary tract infections, and the same virus in your nervous system can cause condition that can affect your brain. These conditions also include encephalitis and meningitis.
The symptoms usually start to subside within two days, however, if the symptoms stay even after three days without any relief, it might be a red flag. The best thing to do during such a situation is to go consult your GP.
Also Read: Unique Symptoms Of Mysterious Adenovirus And How Long Infection Now Last
Experts have noted that due to its ability to stay longer in the environment and being highly transmissible, it is in fact, spreading faster than flu and COVID. Eric Sachinwalla, Jefferson Health's medical director said that this virus is still unfamiliar and thus not much can actually be done to treat adenovirus. Speaking to PhillyMad, he said, "It is pretty contagious because it is heartier than other viruses - soap and water, or everyday disinfectant, won't kill it, so it tends to live in the environment longer."
Since adenovirus spreads through close contact and is resistant to many everyday disinfectants, hygiene remains the key. The best way to stay safe is by avoiding close contact, especially with those who are unwell. You may also keep an eye on your symptoms, including your body temperature and take steps to prevent the virus from spreading by taking precautions, as well as getting the flu jab.
Credits: iStock
The World Health Organization (WHO) on December 24 prequalified two rapid antigen diagnostic tests (Ag-RDTs) for SARS-CoV-2. This virus is known to have caused COVID-19. As per the WHO, these two tests are called SD Biosensor STANDARD Q COVID-19 Ag Test and the ACON Biotech Flowflex SARS-CoV-2 Antigen Rapid Test (Self-Testing).
At first these tests got temporary emergency approval from the WHO during the pandemic. This was done so the countries could start using them quickly even though long-term data was limited. This emergency approval helped the tests reach over 100 countries when they were urgently needed.
The WHO has now given these tests full prequalification, which means it has a stronger and long-term approval. This means that the WHO has thoroughly checked and confirmed that the tests consistently meet global standards for quality, safety, and accuracy.
Even though WHO officially ended COVID-19 emergency phase over two years ago, the virus is still circulating globally. In fact, this year, we have seen variants of COVID-19 circulating around, causing the most unique symptoms, including razor-blade like throat. Variants like JN.1, Stratus, Nimbus, LP8.1, and BA.3.2 were all that we saw in 2025.
While the good news is that infection levels are relatively stable, but the virus has not completely disappeared and testing is still necessary, especially in poorer countries.
Many low-income countries do not have easy access to labs or expensive PCR testing. So there is still a need for a strong, but cheaper and reliable way to detect COVID-19, and these tests may as well do that.
However, it is important to note that rapid antigen tests are not replacement for PCR tests. They simply complement the PCR tests by allowing faster, on-the-spot decisions, especially when the lab capacity is limited.
Rapid antigen tests could help with spotting and stopping local outbreaks quickly, protecting high-risk people and healthcare workers, and staying prepared for future respiratory pandemics.
The WHO is also pushing for decentralized, quality-checked testing as part of universal healthcare and global health security, so countries aren’t caught unprepared when the next outbreak happens.
If you notice these following symptoms as noted by the Centers for Disease Control and Prevention (CDC), it is best that you get yourself a COVID-19 test:
© 2024 Bennett, Coleman & Company Limited